By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Celera today reported that its fourth-quarter sales fell 11 percent as its licensing revenues declined sharply year over year.

The Alameda, Calif.-based molecular diagnostics firm, which announced separately that it will be acquired by Quest Diagnostics for $671 million, brought in total revenues of $34.9 million for the three-month period ended Dec. 25, compared to $39.2 million for Q4 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.